S069-0525 Screening compound: N-cyclopentyl-3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinecarboxamide

S069-0525 Screening compound: N-cyclopentyl-3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinecarboxamide
S069-0525 Screening compound: N-cyclopentyl-3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S069-0525
N-cyclopentyl-3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S069-0525

Molecular Formula

C17H21N5O2 (C17 H21 N5 O2)

Compound Name

N-cyclopentyl-3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinecarboxamide

IUPAC name

N-cyclopentyl-3-[5-(pyridin-3-yl)-124-oxadiazol-3-yl]pyrrolidine-1-carboxamide

SMILES

O=C(NC1CCCC1)N(CC1)CC1c1noc(-c2cnccc2)n1

InChI

InChI=1S/C17H21N5O2/c23-17(19-14-5-1-2-6-14)22-9-7-13(11-22)15-20-16(24-21-15)12-4-3-8-18-10-12/h3-4,8,10,13-14H,1-2,5-7,9,11H2,(H,19,23)/t13-/m1/s1

InChI Key

NOFRLTLXVKGYAN-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD28995217

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

327.39

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.388

Distribution Coefficient, logD

2.295

Water Solubility, LogSw

-2.17

Polar Surface Area

68.344

Acid Dissociation Constant (pKa)

17.55

Base Dissociation Constant (pKb)

6.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.94

S069-0525 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S069-0525 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S069-0525?
Check Price and Availability of S069-0525, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S069-0525 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S069-0525
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S069-0525
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S069-0525 available by request